Law firm Wohl & Fruchter is investigating whether the proposed sale of Cross Country Healthcare to Knox Lane for $13.25 per share is fair to shareholders. The sale price is significantly below the company's 52-week high of $14.99 and substantially lower than a previous acquisition agreement with Aya Healthcare at $18.61 per share that was terminated in December 2025.

The Schall Law Firm is investigating Cross Country Healthcare, Inc. (NASDAQ: CCRN) for potential securities law violations, alleging the company issued false or misleading statements or failed to disclose material information to investors. Shareholders who suffered losses are encouraged to participate in the investigation.

The global healthcare staffing market is projected to grow from USD 45.08 billion in 2025 to USD 76.51 billion by 2033, at a CAGR of 6.87%. Growth is driven by rising patient demand, aging populations, healthcare workforce shortages, and increased adoption of digital staffing platforms and telehealth services. However, labor shortages and regulatory complexities pose challenges to market expansion.

Employbridge has named William Grubbs as its new Interim CEO, replacing Billy Milam who is transitioning to pursue other opportunities. Grubbs brings over 35 years of experience in staffing and workforce solutions, previously serving as President and CEO of Cross Country Healthcare.

The M&A Class Action Firm is investigating the proposed mergers of EMCORE Corporation, Cross Country Healthcare, Inc., William Penn Bancorporation, and AlloVir, Inc. and encouraging shareholders to act now.

Halper Sadeh LLC is investigating potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders related to the proposed sales of Cross Country Healthcare, EnLink Midstream, Interpublic Group, and Enterprise Bancorp.

Brodsky & Smith is investigating several acquisition deals, including those involving Universal Stainless & Alloy Products, Patterson Companies, Cross Country Healthcare, and EnLink Midstream, to determine if the target companies' boards breached their fiduciary duties by failing to conduct a fair process and ensure fair value for shareholders.

Halper Sadeh LLC, an investor rights law firm, is investigating potential violations of federal securities laws and breaches of fiduciary duties to shareholders related to the proposed sales of Cross Country Healthcare, Arcadia Biosciences, and EnLink Midstream.

Cross Country Healthcare has agreed to be acquired by Aya Healthcare for $18.61 per share, a 67% premium over the previous closing price. The merger will expand Aya's services and provide growth opportunities for employees.

The UAE dietary supplements market is projected to grow at a robust CAGR of 7.28% by 2029, driven by increasing health consciousness and rising disposable incomes among consumers. The market is experiencing a surge in demand for diverse supplement offerings to meet various health needs.

Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.

Throughout the last three months, 4 analysts have evaluated Cross Country Healthcare (NASDAQ:CCRN), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.0, a high estimate of $24.00, and a low estimate of $16.00. This current average has decreased by 13.98% from the previous average price target of $23.25. Interpreting Analyst Ratings: A Closer Look A clear picture of Cross Country Healthcare's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Bill Sutherland Benchmark Lowers Buy $19.00 $21.00 Kevin Steinke Barrington Research Lowers Outperform $24.00 $26.00 Tobey Sommer Truist Securities Lowers Hold $16.00 $22.00 Bill Sutherland Benchmark Lowers Buy $21.00 $24.00 Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Cross Country Healthcare. This information offers a snapshot of how analysts perceive the current state ...Full story available on Benzinga.com